Douglas Black

2.0k total citations
29 papers, 461 citations indexed

About

Douglas Black is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Douglas Black has authored 29 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in General Health Professions. Recurrent topics in Douglas Black's work include HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Douglas Black is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Douglas Black collaborates with scholars based in United States, Uganda and Kenya. Douglas Black's co-authors include Diane V. Havlir, Mark Z. Jacobson, Elizabeth Sinclair, Gabriel Chamie, Barry M. Bredt, C. Lorrie Epling, Alexander Carvidi, Stuart P. Adler, Maya L. Petersen and Moses R. Kamya and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Douglas Black

24 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Black United States 13 238 193 69 35 34 29 461
Rachael M. Burke United Kingdom 13 375 1.6× 300 1.6× 24 0.3× 18 0.5× 31 0.9× 39 552
Nathan W. Furukawa United States 10 380 1.6× 231 1.2× 64 0.9× 26 0.7× 79 2.3× 21 644
H. Nina Kim United States 15 255 1.1× 259 1.3× 114 1.7× 7 0.2× 73 2.1× 45 646
Laura H. Thompson Canada 17 308 1.3× 365 1.9× 103 1.5× 6 0.2× 41 1.2× 54 748
Melissa Briggs‐Hagen United States 9 267 1.1× 57 0.3× 59 0.9× 10 0.3× 34 1.0× 16 374
Davide Mangioni Italy 13 273 1.1× 100 0.5× 46 0.7× 11 0.3× 28 0.8× 32 614
Mrudula Phadke India 16 357 1.5× 248 1.3× 141 2.0× 7 0.2× 45 1.3× 42 566
Kifle Lentiro Ethiopia 7 164 0.7× 100 0.5× 68 1.0× 8 0.2× 34 1.0× 8 337
Anne M. Neilan United States 16 419 1.8× 169 0.9× 125 1.8× 12 0.3× 32 0.9× 47 723
Mariana Siapka United Kingdom 11 256 1.1× 225 1.2× 81 1.2× 9 0.3× 17 0.5× 18 419

Countries citing papers authored by Douglas Black

Since Specialization
Citations

This map shows the geographic impact of Douglas Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Black more than expected).

Fields of papers citing papers by Douglas Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Black. The network helps show where Douglas Black may publish in the future.

Co-authorship network of co-authors of Douglas Black

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Black. A scholar is included among the top collaborators of Douglas Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Black. Douglas Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurie, Matthew T., Jamin Liu, Sara Sunshine, et al.. (2022). SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. The Journal of Infectious Diseases. 225(11). 1909–1914. 29 indexed citations
2.
3.
Mwangwa, Florence, Edwin D. Charlebois, James Ayieko, et al.. (2022). Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya. AIDS Care. 35(1). 95–105. 3 indexed citations
4.
Marquez, Carina, Andrew D. Kerkhoff, Susana Rojas, et al.. (2022). COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA Network Open. 5(10). e2235844–e2235844. 22 indexed citations
5.
Petersen, Maya L., Elizabeth A. Bukusi, Moses R. Kamya, et al.. (2021). Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya. PLoS ONE. 16(2). e0243167–e0243167. 7 indexed citations
6.
Kerkhoff, Andrew D., Darpun Sachdev, Susy Rojas, et al.. (2020). Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations. PLoS ONE. 15(10). e0239400–e0239400. 39 indexed citations
7.
Koss, Catherine A., James Ayieko, Florence Mwangwa, et al.. (2018). Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clinical Infectious Diseases. 67(12). 1853–1860. 23 indexed citations
8.
Jain, Vivek, Wei Chang, Dathan M. Byonanebye, et al.. (2015). Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS ONE. 10(12). e0143433–e0143433. 13 indexed citations
9.
Jain, Vivek, Dathan M. Byonanebye, Teri Liegler, et al.. (2013). Changes in Population HIV RNA Levels in Mbarara, Uganda, During Scale-up of HIV Antiretroviral Therapy Access. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3). 327–332. 13 indexed citations
10.
Jain, Vivek, Teri Liegler, Jane Kabami, et al.. (2012). Assessment of Population-Based HIV RNA Levels in a Rural East African Setting Using a Fingerprick-Based Blood Collection Method. Clinical Infectious Diseases. 56(4). 598–605. 27 indexed citations
11.
Black, Douglas, et al.. (2010). D-lactic acidosis and ataxia in a man with Crohn disease. Canadian Medical Association Journal. 182(3). 276–279. 6 indexed citations
12.
Jacobson, Mark Z., Stuart P. Adler, Elizabeth Sinclair, et al.. (2009). A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine. 27(10). 1540–1548. 33 indexed citations
13.
Jacobson, Mark Z., Elizabeth Sinclair, Barry M. Bredt, et al.. (2006). Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. Journal of Clinical Virology. 35(3). 332–337. 30 indexed citations
14.
Jacobson, Mark Z., Elizabeth Sinclair, Barry M. Bredt, et al.. (2006). Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12. Vaccine. 24(25). 5311–5319. 32 indexed citations
15.
Sinclair, Elizabeth, Douglas Black, C. Lorrie Epling, et al.. (2004). CMV Antigen-Specific CD4 + and CD8 + T Cell IFNγ Expression and Proliferation Responses in Healthy CMV-Seropositive Individuals. Viral Immunology. 17(3). 445–454. 30 indexed citations
16.
Black, Douglas. (1998). The Limitations of Evidence. Journal of the Royal College of Physicians of London. 32(1). 23–26. 1 indexed citations
17.
Black, Douglas. (1994). A Doctor Looks at Health Economics. OpenGrey (Institut de l'Information Scientifique et Technique). 11 indexed citations
18.
Black, Douglas. (1988). HEALTH AND DEPRIVATION: Inequality and the north. Europe PMC (PubMed Central). 38(310). 234–234. 9 indexed citations
19.
Black, Douglas. (1985). Medical Accountability. Journal of the Royal College of Physicians of London. 19(4). 203–204. 1 indexed citations
20.
Black, Douglas. (1974). ORGANIZATION OF HEALTH SERVICES RESEARCH. British Medical Bulletin. 30(3). 199–202.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael M. Burke Breakdown of academic impact, for papers by Nathan W. Furukawa Breakdown of academic impact, for papers by H. Nina Kim Breakdown of academic impact, for papers by Laura H. Thompson Breakdown of academic impact, for papers by Melissa Briggs‐Hagen Breakdown of academic impact, for papers by Davide Mangioni Breakdown of academic impact, for papers by Mrudula Phadke Breakdown of academic impact, for papers by Kifle Lentiro Breakdown of academic impact, for papers by Anne M. Neilan Breakdown of academic impact, for papers by Mariana Siapka
Rankless by CCL
2026